Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Revive Therapeutics Ltd (RVV.CN)

Revive Therapeutics Ltd (RVV.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 152,188
  • Shares Outstanding, K 317,059
  • Annual Sales, $ 0 K
  • Annual Income, $ -5,382 K
  • 60-Month Beta 0.12
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.86
Trade RVV.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.07
  • Most Recent Earnings -0.01 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.370 +31.08%
on 09/02/21
0.540 -10.19%
on 09/09/21
+0.060 (+14.12%)
since 08/27/21
3-Month
0.345 +40.58%
on 08/11/21
0.650 -25.38%
on 07/05/21
-0.025 (-4.90%)
since 06/28/21
52-Week
0.175 +177.14%
on 10/29/20
0.920 -47.28%
on 12/14/20
+0.195 (+67.24%)
since 09/28/20

Most Recent Stories

More News
ETF Inclusion Sends Psychedelic Stock Soaring

There are a few different events that can take place that naturally create buying pressure for a stock. ...

RVV.CN : 0.485 (+1.04%)
Revive Therapeutics Included in AdvisorShares(R) Newly Launched Psychedelics ETF

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs...

RVVTF : 0.3805 (+0.13%)
RVV.CN : 0.485 (+1.04%)
PSIL : 9.27 (-2.22%)
Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs...

RVVTF : 0.3805 (+0.13%)
RVV.CN : 0.485 (+1.04%)
Revive Confirms No Material Undisclosed Information

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (Frankfurt:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs...

RVVTF : 0.3805 (+0.13%)
RVV.CN : 0.485 (+1.04%)
Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs...

RVVTF : 0.3805 (+0.13%)
RVV.CN : 0.485 (+1.04%)
PHRRF : 0.4779 (+0.38%)
PHRM.CN : 0.610 (+1.67%)
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs...

RVVTF : 0.3805 (+0.13%)
RVV.CN : 0.485 (+1.04%)
The Digital Transformation of Healthcare Creating Substantial Opportunity

Demand for digital health technology is on the rise. According to Digital Authority Partners, “Telemedicine, ...

RVV.CN : 0.485 (+1.04%)
RVVTF : 0.3805 (+0.13%)
MYCOF : 0.2728 (-1.62%)
EPWCF : 0.3464 (-5.54%)
DOC.VN : 1.560 (-3.11%)
DOCRF : 1.2400 (-2.86%)
AIMLF : 0.5325 (-1.39%)
DOC.CN : 2.065 (+190.85%)
CBDT.CN : 0.440 (-4.35%)
AIML.CN : 0.640 (-5.88%)
Revive Therapeutics Approved to Trade on the OTCQB Market

Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE: RVV, USA: RVVTF, FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs...

RVV.CN : 0.485 (+1.04%)
RVVTF : 0.3805 (+0.13%)
Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelics

Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE: RVV, USA: RVVTF, Frankfurt: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs...

RVV.CN : 0.485 (+1.04%)
RVVTF : 0.3805 (+0.13%)
Revive To Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference

Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE: RVV, USA: RVVTF, Frankfurt: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs...

RVV.CN : 0.485 (+1.04%)
RVVTF : 0.3805 (+0.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.532
2nd Resistance Point 0.508
1st Resistance Point 0.497
Last Price 0.485
1st Support Level 0.462
2nd Support Level 0.438
3rd Support Level 0.427

See More

52-Week High 0.920
Fibonacci 61.8% 0.635
Fibonacci 50% 0.547
Last Price 0.485
Fibonacci 38.2% 0.460
52-Week Low 0.175

See More

Business Summary

Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar